![Paul E. Gargan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul E. Gargan
Fondateur chez Prominex, Inc. (California)
Postes actifs de Paul E. Gargan
Sociétés | Poste | Début | Fin |
---|---|---|---|
Gen-Probe, Inc.
![]() Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/1997 | - |
Prominex, Inc. (California)
![]() Prominex, Inc. (California) Medical SpecialtiesHealth Technology Prominex, Inc. manufactures molecular diagnostic assays for infectious disease testing. The company was founded by Paul Thomas and Paul Gargan in 2017 and is headquartered in San Diego, CA. | Fondateur | 01/01/2017 | - |
Corporate Officer/Principal | 01/01/2017 | - |
Historique de carrière de Paul E. Gargan
Anciens postes connus de Paul E. Gargan
Sociétés | Poste | Début | Fin |
---|---|---|---|
SORRENTO TECH INC | Directeur/Membre du Conseil | 24/02/2011 | - |
QHSLAB, INC. | Directeur Technique/Scientifique/R&D | 24/02/2011 | - |
President | - | - |
Formation de Paul E. Gargan
Queen's University | Doctorate Degree |
University of Notre Dame | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
QHSLAB, INC. | Finance |
Entreprise privées | 3 |
---|---|
Gen-Probe, Inc.
![]() Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Sorrento Tech, Inc.
![]() Sorrento Tech, Inc. Medical SpecialtiesHealth Technology Sorrento Tech, Inc., also known as Roka Bio Science, is a private company that specializes in food safety technology. The company is based in Warren, NJ and has subsidiaries in the United States. The company's core technology is the Roka pathogen detection assays, which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to deliver a fully automated, single-protocol assay with reduced enrichment times and superior sensitivity. The company's products include the Atlas® system and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bio Science provides solutions for the beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing industries. Roka Bio Science was founded in 2009 by Paul G. Thomas. | Health Technology |
Prominex, Inc. (California)
![]() Prominex, Inc. (California) Medical SpecialtiesHealth Technology Prominex, Inc. manufactures molecular diagnostic assays for infectious disease testing. The company was founded by Paul Thomas and Paul Gargan in 2017 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Paul E. Gargan
- Expérience